Brain metastasis from melanoma.

Area of Science:

• Neuro-oncology
• Melanoma Research
• Cancer Metastasis

Background:

• Brain metastases are a significant complication of melanoma.
• Melanoma brain metastases present unique challenges in diagnosis and treatment.
• Seizures are a common neurological complication.

Purpose of the Study:

• To analyze treatment outcomes for melanoma patients with brain metastases.
• To evaluate the efficacy of radiation therapy (RT) and surgery.
• To assess the role of prophylactic anticonvulsants and steroid dependency.

Main Methods:

• Retrospective analysis of 81 melanoma patients with brain metastases treated at MSKCC (1978-1980).
• Patients categorized into groups based on metastasis burden and treatment: RT for multiple metastases, RT for single metastasis, and surgery with or without RT for single metastasis.
• Survival, steroid dependency, and seizure incidence were analyzed.

Main Results:

• Median survival varied significantly by treatment group: 11 weeks (multiple metastases, RT), 9 weeks (single metastasis, RT), and 41 weeks (single metastasis, surgery).
• Hemorrhagic metastases occurred in 29% of patients with non-contrast CT scans.
• Seizures affected 48% of patients, often as the first sign of metastasis. Prophylactic anticonvulsants reduced seizure incidence.

Conclusions:

• Surgical resection should be considered for highly selected patients with single brain metastases from melanoma.
• Radiation therapy remains a primary treatment modality for multiple brain metastases.
• Prophylactic anticonvulsant therapy is advisable to mitigate seizure risk in patients with brain metastases.